Related references
Note: Only part of the references are listed.Brain cortical cholesterol metabolism is highly affected by human APP overexpression in mice
Tina Loeffler et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2016)
A New Paradigm for the Treatment of Alzheimer's Disease: Targeting Vascular Activation
Paula Grammas et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Neuroinflammation and related neuropathologies in APPSL mice: further value of this in vivo model of Alzheimer's disease
Tina Loeffler et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Blood-brain-barriers in aging and in Alzheimer's disease
Fernanda Marques et al.
MOLECULAR NEURODEGENERATION (2013)
Amyloid-β Contributes to Blood-Brain Barrier Leakage in Transgenic Human Amyloid Precursor Protein Mice and in Humans With Cerebral Amyloid Angiopathy
Anika M. S. Hartz et al.
STROKE (2012)
High calorie diet triggers hypothalamic angiopathy
Chun-Xia Yi et al.
MOLECULAR METABOLISM (2012)
Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?
Christian Humpel
EXPERIMENTAL GERONTOLOGY (2011)
A Longitudinal Study of Behavioral Deficits in an A beta PP Transgenic Mouse Model of Alzheimer's Disease
Daniel Havas et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Amyloid Triggers Extensive Cerebral Angiogenesis Causing Blood Brain Barrier Permeability and Hypervascularity in Alzheimer's Disease
Kaan E. Biron et al.
PLOS ONE (2011)
Post-prandial lipid metabolism, lipid-modulating agents and cerebrovascular integrity: Implications for dementia risk
Menuka M. S. Pallebage-Gamarallage et al.
ATHEROSCLEROSIS SUPPLEMENTS (2010)
DHA Diet Reduces AD Pathology in Young APPswe/PS1ΔE9 Transgenic Mice: Possible Gender Effects
Sylvia E. Perez et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2010)
Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease
Robert D. Bell et al.
ACTA NEUROPATHOLOGICA (2009)
Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests
K. A. Bates et al.
MOLECULAR PSYCHIATRY (2009)
Soluble aggregates of the amyloid-β protein selectively stimulate permeability in human brain microvascular endothelial monolayers
Francisco J. Gonzalez-Velasquez et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Plasma lipoprotein β-amyloid in subjects with Alzheimer's disease or mild cognitive impairment
J. C. L. Mamo et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2008)
β-amyloid or its precursor protein is found in epithelial cells of the small intestine and is stimulated by high-fat feeding
Susan Galloway et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2007)
Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice
M. Oksman et al.
NEUROBIOLOGY OF DISEASE (2006)
Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloidβ protein 40 in wild-type and Alzheimer's disease transgenic mice (APP, PS1) and its implications for amyloid plaque formation
KK Kandimalla et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective
RE Tanzi et al.
CELL (2005)
TGF-β2-induced cell surface tissue transglutaminase increases adhesion and migration of RPE cells on fibronectin through the gelatin-binding domain
SG Priglinger et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Aβ-induced vascular oxidative stress and attenuation of functional hyperemia in mouse somatosensory cortex
L Park et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2004)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
Alzheimer's disease: the cholesterol connection
L Puglielli et al.
NATURE NEUROSCIENCE (2003)
Tyrosine phosphorylation and dissociation of occludin-Z0-1 and E-cadherin-β-catenin complexes from the cytoskeleton by oxidative stress
RK Rao et al.
BIOCHEMICAL JOURNAL (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease
JF Poduslo et al.
NEUROBIOLOGY OF DISEASE (2001)
Cerebral microvascular pathology in aging and Alzheimer's disease
E Farkas et al.
PROGRESS IN NEUROBIOLOGY (2001)
Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
M Shibata et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Modulation of amyloid β-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway
DE Kang et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons
J Van Dorpe et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model
LM Refolo et al.
NEUROBIOLOGY OF DISEASE (2000)
Share Paper
